OS | PFS | LPFS | ||||||||||
Univariable | Multivariable | Univariable | Multivariable | Univariable | Multivariable | |||||||
Characteristic | HR | P | HR | P | HR | P | HR | P | HR | P | Hazard ratio | P |
Age* | 1.26 (0.86–1.83) | 0.23 | 1.43 (0.95–2.17) | 0.09 | 1.03 (0.74–1.44) | 0.85 | 0.84 (0.50–1.39) | 0.49 | ||||
Male sex | 1.13 (0.56–2.28) | 0.73 | 1.29 (0.68–2.46) | 0.44 | 0.94 (0.36–2.48) | 0.90 | ||||||
Stage 1 or 2 | 1 | 0.42 | 1 | 0.81 | 1 | 0.64 | ||||||
Stage 3a | 0.90 (0.32–2.56) | 1.38 (0.51–3.72) | 1.67 (0.36–7.70) | |||||||||
Stage 3b | 1.47 (0.52–4.16) | 1.28 (0.47–3.49) | 1.06 (0.21–5.49) | |||||||||
Squamous cell carcinoma histology | 1.04 (0.48–2.26) | 0.91 | 0.86 (0.44–1.69) | 0.67 | 0.57 (0.19–1.75) | 0.33 | ||||||
SUVpeak† | 0.87 (0.63–1.18) | 0.36 | 0.87 (0.65–1.16) | 0.34 | 0.82 (0.54–1.24) | 0.35 | ||||||
TLG‡ | 0.93 (0.72–1.21) | 0.59 | 0.82 (0.64–1.05) | 0.11 | 1.06 (0.74–1.51) | 0.76 | 0.73 (0.53–0.99) | 0.04 | 0.91 (0.59–1.41) | 0.68 | ||
High coarseness | 3.48 (1.41–8.63) | 0.007 | 4.86 (1.32–17.9) | 0.02 | 3.18 (1.48–6.85) | 0.003 | 2.41 (0.82–7.09) | 0.11 | 6.69 (1.50–29.8) | 0.01 | 5.56 (0.90–34.1) | 0.06 |
High contrast | 0.47 (0.20–1.10) | 0.08 | 1.11 (0.41–2.99) | 0.84 | 0.40 (0.19–0.85) | 0.02 | 0.60 (0.24–1.48) | 0.27 | 0.30 (0.09–1.07) | 0.07 | 0.67 (0.16–1.48) | 0.58 |
High busyness | 0.51 (0.25–1.04) | 0.06 | 1.12 (0.44–2.92) | 0.80 | 0.46 (0.24–0.88) | 0.02 | 0.97 (0.37–2.53) | 0.95 | 0.36 (0.13–0.98) | 0.05 | 1.18 (0.32–2.53) | 0.80 |
High complexity | 0.59 (0.28–1.25) | 0.17 | 1.11 (0.43–2.87) | 0.82 | 0.61 (0.32–1.18) | 0.17 | 0.87 (0.40–1.92) | 0.73 | 0.60 (0.22–1.62) | 0.31 |
↵* Hazard ratios are reported for 10-unit increase in variable.
↵† Hazard ratios are reported for 5-unit increase in variable.
↵‡ Variable was analyzed on log scale.
Figures reported are hazard ratios and corresponding 95% CIs. For variables measured on continuous scale, hazard ratios are reported for 1-unit increase in that variable (unless otherwise indicated). Data in parentheses are 95% CIs.